MSME (Udyam registered) Ministry of MSME
- Category
- Medium (2024-25)
- Udyam number
- UDYAM-TN-02-0044674
Neuberg Ehrlich Laboratory Private Limited - healthcare in Chennai, Tamil Nadu, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹94.56 Cr
▼ 24% YoY
Net loss · FY 2025
₹6.68 Cr
Net margin -7.1%
EBITDA · FY 2025
₹40.93 Lakh
EBITDA margin 0.4%
Authorised capital
₹50 Lakh
Registered with MCA
Paid-up capital
₹31.78 Lakh
Issued & subscribed
Open charges
₹62.81 Cr
Secured borrowings
Company age
47 yrs
Est. 1979
Employees · EPFO
560
Provident fund records
About Neuberg Ehrlich Laboratory Private Limited
Data last updated:
Neuberg Ehrlich Laboratory Private Limited is a private limited company based in Chennai, Tamil Nadu, India, a subsidiary of Neuberg Diagnostics Private Limited. It operates in the diagnostic centers and pathology labs segment of the healthcare sector. It was incorporated on 07 March 1979 and has been in existence for over 47 years.
The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U85195TN1979PTC007745. Its GSTIN is 33AAACE7177K1ZG (Tamil Nadu). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹50 Lakh and a paid-up capital of ₹31.78 Lakh. It was formerly known as Ehrlich Laboratory Private Limited. It is led by directors Athmanathan Ganesan and Kavya K Velu.
Its last annual general meeting (AGM) was held on 29 September 2025, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Plot No. 7 Industrial Estate, Perungudi Chennai, Tamil Nadu, India – 600096.
As per the financials filed for FY 2025, the company reported a revenue of ₹94.56 Cr, a decline of 24% compared to the previous year. For the same year it recorded a net loss of ₹6.68 Cr (net margin -7.1%) and EBITDA of ₹40.93 Lakh (EBITDA margin 0.4%). Revenue has grown at a compounded annual rate (CAGR) of 5% over three years and 23% over five years.
The company has about 560 employees on its provident fund (EPFO) records. Its group structure includes 2 subsidiaries.
As per MCA filings, the company has open charges of ₹62.81 Cr on record. Court records list 5 cases involving the company, including 5 filed by the company; 3 cases are pending. The company has 3 deals on record (3 secondary share transfers); the latest was in August 2019. Its 10 peer companies in the Healthcare industry (Diagnostics and Pathology Labs) are compared by revenue, 5 larger and 5 smaller; the largest is CRL Diagnostics Private Limited with revenue of ₹101.01 Cr. The company has 11 MSME Form 1 returns on record between 2021 and 2024, listing 2,469 overdue payments to 39 micro and small suppliers.
Neuberg Ehrlich Laboratory Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-TN-02-0044674). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website neubergdiagnostics.com.
Company Details of Neuberg Ehrlich Laboratory Private Limited
CIN U85195TN1979PTC007745
Registration Number 007745
Incorporation Date 07 March 1979
ROC Chennai
Listing Status Unlisted
Company Status Active
Date of Last AGM 29 September 2025
Date of Balance Sheet 31 March 2024
Parent Company Neuberg Diagnostics Private Limited
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-TN-02-0044674
Recognitions & Rankings of Neuberg Ehrlich Laboratory
Contact Details
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressPlot No. 7 Industrial Estate, Perungudi Chennai, Tamil Nadu, India – 600096
- IndustryHealthcare, Diagnostic Centers & Pathology Labs
Comprehensive company report
Neuberg Ehrlich Laboratory Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business Activity of Neuberg Ehrlich Laboratory Private Limited
The main business activity of Neuberg Ehrlich Laboratory is hospital and medical care. In detail, this covers medical and dental practice, nursing, pathology, blood bank services, etc..
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q2 | Medical and dental practice, Nursing, pathology, blood bank services, etc. | Locked |
Premium access
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Neuberg Ehrlich Laboratory Private Limited FY 2024 filings available
Neuberg Ehrlich Laboratory Private Limited reported revenue of ₹94.56 Cr (down 24% YoY) for FY 2025.
Revenue · FY 2025
₹94.56 Cr ▼ 24%
Net loss · FY 2025
₹6.68 Cr margin -7.1%
EBITDA · FY 2025
₹40.93 Lakh margin 0.4%
Compounded Annual Growth Rate (CAGR) of Neuberg Ehrlich Laboratory Private Limited
Revenue CAGR growth
1 year
▼ 24%
3 years · compounded
▼ 5%
5 years · compounded
▲ 23%
EBITDA CAGR growth
1 year
▼ 97%
3 years · compounded
▼ 73%
5 years · compounded
▼ 37%
Revenue fell 24% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 23%. EBITDA fell 97% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Neuberg Ehrlich Laboratory Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹40.93 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹6.68 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Neuberg Ehrlich Laboratory Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.4% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -7.1% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Neuberg Ehrlich Laboratory are in the company report.
Premium access
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Neuberg Ehrlich Laboratory Private Limited
Neuberg Ehrlich Laboratory has 2 current directors and 11 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Athmanathan Ganesan Also directs: Stakeboat Capital LLP, Athma Business Consulting LLP, Stakeboat Ventures LLP and 5 more | Director | 04 Dec 2017 | 8 Years 10 Months | Current |
| Kavya K Velu Also directs: Neuberg Bose Laboratories Private Limited, Gemini Scans Private Limited, Neuberg Sehgal Path Lab Private Limited and 5 more | Director | 05 Jul 2024 | 2 Years 3 Months | Current |
Peer Comparison of Neuberg Ehrlich Laboratory Private Limited
Neuberg Ehrlich Laboratory Private Limited is compared with the companies closest to it by revenue in the Healthcare industry (Diagnostics and Pathology Labs). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| CRL Diagnostics Private Limited | ₹101.01 Cr (FY 2025) | •••• | •••• | 31.0% | •••• | New Delhi, Delhi, India |
| Lupin Diagnostics Limited | ₹98.57 Cr (FY 2025) | •••• | •••• | 42.0% | •••• | Mumbai, Maharashtra, India |
| Oncquest Laboratories Limited | ₹97.99 Cr (FY 2025) | •••• | •••• | 0.0% | •••• | New Delhi, Delhi, India |
| Lucid Medical Diagnostics Private Limited | ₹94.91 Cr (FY 2025) | •••• | •••• | 2.0% | •••• | Hyderabad, Telangana, India |
| Accuprobe Healthcare and Diagnostics Private Limited | ₹94.78 Cr (FY 2025) | •••• | •••• | 35.0% | •••• | Delhi, India |
| Neuberg Ehrlich Laboratory Private Limited this company | ₹94.56 Cr (FY 2025) | •••• | •••• | -24.0% | •••• | Chennai, Tamil Nadu, India |
| Universal Medicap Limited | ₹91.31 Cr (FY 2025) | •••• | •••• | 18.0% | •••• | Vadodara, Gujarat, India |
| Konnect Imaging and Diagnostics Private Limited | ₹86.55 Cr (FY 2025) | •••• | •••• | 20.0% | •••• | Hyderabad, Telangana, India |
| Atulaya Healthcare Private Limited | ₹85.65 Cr (FY 2024) | •••• | •••• | 21.0% | •••• | Chandigarh, India |
| Dr Dangs Lab LLP | ₹85.08 Cr (FY 2025) | •••• | •••• | 26.0% | •••• | New Delhi, Delhi, India |
| Dishari Health Point Private Limited | ₹84.83 Cr (FY 2024) | •••• | •••• | 28.0% | •••• | Malda, West Bengal, India |
Peers are the five companies nearest above and the five nearest below Neuberg Ehrlich Laboratory by revenue in the Healthcare industry (Diagnostics and Pathology Labs), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Neuberg Ehrlich Laboratory Private Limited
Neuberg Ehrlich Laboratory Private Limited is audited by MSKA & Associates for the financial year 2022.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| MSKA & Associates | Locked | Locked | Locked |
Premium access
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Neuberg Ehrlich Laboratory Private Limited
Premium access
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Neuberg Ehrlich Laboratory Private Limited
Open charges
₹62.81 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 22 Aug 2025 | Hdfc Bank Limited | ₹35 Lakh | Open |
| 27 Jun 2025 | Hdfc Bank Limited | ₹2.5 Cr | Open |
| 12 Jun 2024 | Hdfc Bank Limited | ₹6.7 Cr | Open |
| 28 Jul 2023 | Standard Chartered Bank | ₹16.29 Cr | Open |
| 28 Jul 2023 | Hdfc Bank Limited | ₹12 Cr | Open |
Total charge records: 13 View all charges
Deals & Funding of Neuberg Ehrlich Laboratory Private Limited
Neuberg Ehrlich Laboratory Private Limited has 3 deals on record (3 secondary share transfers); the latest was in August 2019.
Total deals
3
Secondary share transfers
3
Deals on record (3 of 3)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Aug 2019 | Secondary share transfer | Undisclosed | Buyer: 2 individuals Seller: an individual |
| Mar 2018 | Secondary share transfer | Undisclosed | Buyer: Kavery Medical Care (Trichy) Limited Seller: 3 individuals |
| Mar 2012 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
Premium access
Full deal history
All 3 deals with amounts, valuations, instruments and every party are in the company report.
- Every funding round and share transfer
- Amounts and valuations
- Investors, buyers and sellers
- Instruments and deal dates
Verified entity values are shown only after access is granted.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal Cases of Neuberg Ehrlich Laboratory Private Limited
Neuberg Ehrlich Laboratory Private Limited has 5 court cases on record: 5 filed by Neuberg Ehrlich Laboratory. 3 cases are pending and 2 are disposed. Status as checked between 21 Sep 2026 and 04 Oct 2026.
Total cases
5
Filed by the company
5
Pending
3
Disposed
2
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 5 | 0 | 3 |
Cases on record (5 of 5)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Chennai, Tamil Nadu | Civil suit | Filed by the company against Innovative Interiors Private Limited | Disposed |
| District court, Chennai, Tamil Nadu | Criminal case | Filed by the company against an individual | Pending |
| District court, Chennai, Tamil Nadu | Criminal case | Filed by the company against Mullai Srinivasam Hospital Pvt Ltd | Pending |
| District court, Chennai, Tamil Nadu | Criminal complaint | Filed by the company against an individual | Pending |
| District court, Chennai, Tamil Nadu | Criminal miscellaneous application | Filed by the company | Disposed |
Premium access
Full case history
All 5 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME Payment Delays by Neuberg Ehrlich Laboratory Private Limited
Neuberg Ehrlich Laboratory Private Limited has 11 MSME Form 1 returns on record between 2021 and 2024, listing 2,469 overdue payments to 39 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 39)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Biosystems Diagnostics Private Limited | •••• | •••• | •••• |
| an individual supplier | •••• | •••• | •••• |
| an individual supplier | •••• | •••• | •••• |
| Radiant Specialty Diagnostics | •••• | •••• | •••• |
| HSB Biopharma | •••• | •••• | •••• |
Premium access
Full MSME payment history
Every supplier, amount and due date from all 11 MSME Form 1 returns is in the company report.
- Every reported supplier due
- Amounts and due dates
- Reasons given in each return
- Period-by-period history
Verified entity values are shown only after access is granted.
Individuals and sole proprietors among the suppliers are not named. Amounts, due dates and filing dates are in the company report.
Employees and EPFO Compliance at Neuberg Ehrlich Laboratory Private Limited
Neuberg Ehrlich Laboratory Private Limited has a workforce of 560 employees as of Mar 30, 2024.
Employee count
560
Active EPFO establishments
1
Employee growth
-9.09%
Premium access
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Group Structure of Neuberg Ehrlich Laboratory Private Limited
Neuberg Ehrlich Laboratory has 2 subsidiary companies and 1 associated company. This group structure data is as of FY 2023. The table lists each entity with its relationship and holding.
2
Subsidiary companies
1
Associated companies
Key Subsidiaries
| Company Name | CIN | Shares Held |
|---|---|---|
| Neuberg Bose Laboratories Private Limited | U24299TN2021PTC148870 | Locked |
| Neuberg Express Laboratories Private Limited | U85110TN2022PTC150495 | Locked |
Showing major subsidiaries. Total: 2.
Recent Activity on Neuberg Ehrlich Laboratory Private Limited
Neuberg Ehrlich Laboratory Private Limited has 13 board changes on record since 2009: 2 appointments and 11 cessations. The latest: Sandhya Subramanyam ceased to be Director on 28 Apr 2025.
AGM
Neuberg Ehrlich Laboratory Private Limited last Annual general meeting of members was held on 29 Sep 2025 as per latest MCA records.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 35.00 Lakh with Charge ID 101199956 was registered on 22 Aug 2025.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 250.00 Lakh with Charge ID 101122181 was registered on 27 Jun 2025.
Ceased
Sandhya Subramanyam ceased to be Director.
Ceased
Kavya K Velu ceased to be Additional Director.
Appointed
Kavya K Velu was appointed as Director.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 669.94 Lakh with Charge ID 100948782 was registered on 12 Jun 2024.
Ceased
Selvaraj Manivannan ceased to be Nominee Director.
Filing
Neuberg Ehrlich Laboratory Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Chennai.
Charges
A charge with Standard Chartered Bank amounted to Rs. 1,629.00 Lakh with Charge ID 100756151 was registered on 28 Jul 2023.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 1,200.00 Lakh with Charge ID 100773722 was registered on 28 Jul 2023.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 1,200.00 Lakh with Charge ID 100773724 was registered on 28 Jul 2023.
19 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Neuberg Ehrlich Laboratory Private Limited
Premium access
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Neuberg Ehrlich Laboratory Private Limited
Premium access
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Neuberg Ehrlich Laboratory Private Limited
Neuberg Ehrlich Laboratory has 2 GST registrations: 2 active.
Total GSTINs
2
Active
2
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 33AAACE7177K1ZG | Tamil Nadu | Active | 06 Jul 2017 |
| 34AAACE7177K1ZE | Puducherry | Active | 22 Feb 2024 |
Premium access
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Neuberg Ehrlich Laboratory Private Limited
Premium access
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Related news about Neuberg Ehrlich Laboratory Private Limited
Frequently Asked Questions about Neuberg Ehrlich Laboratory Private Limited
Neuberg Ehrlich Laboratory is an active private limited company based in Chennai, Tamil Nadu, India. The company works in diagnostic centers and pathology labs, within the healthcare industry. It was incorporated on 07 March 1979 (47+ years old) and is registered under CIN U85195TN1979PTC007745.
Neuberg Ehrlich Laboratory reported revenue of ₹94.56 Cr for FY 2025 (down 24% YoY).
Neuberg Ehrlich Laboratory has 2 current directors:
- Athmanathan Ganesan - Director
- Kavya K Velu - Director
Neuberg Ehrlich Laboratory reported a net loss of ₹6.68 Cr (net margin -7.1%) and EBITDA of ₹40.93 Lakh (EBITDA margin 0.4%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Neuberg Ehrlich Laboratory is -5% over three years and 23% over five years. In the latest year (FY 2025) revenue fell 24%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Neuberg Ehrlich Laboratory is 33AAACE7177K1ZG, registered in Tamil Nadu. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 34AAACE7177K1ZE (Puducherry).
The CIN (Corporate Identification Number) of Neuberg Ehrlich Laboratory is U85195TN1979PTC007745. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Neuberg Ehrlich Laboratory has 5 court cases on record: 5 filed by the company. 3 are pending.
Neuberg Ehrlich Laboratory was incorporated on 07 March 1979, making it 47+ years old. It is registered with the Registrar of Companies, Chennai.
Neuberg Ehrlich Laboratory has 3 deals on record (3 secondary share transfers); the latest was in August 2019.
The peers of Neuberg Ehrlich Laboratory by revenue are CRL Diagnostics Private Limited, Lupin Diagnostics Limited, Oncquest Laboratories Limited, Lucid Medical Diagnostics Private Limited, Accuprobe Healthcare and Diagnostics Private Limited and 5 more, all in the Healthcare industry (Diagnostics and Pathology Labs).
Sandhya Subramanyam ceased to be Director on 28 Apr 2025. Kavya K Velu ceased to be Additional Director on 25 Sep 2024. Kavya K Velu was appointed as Director on 05 Jul 2024. Neuberg Ehrlich Laboratory has 13 board changes on record in total.